PortfoliosLab logo
PortfoliosLab logo
Tools
Performance Analysis
Portfolio Analysis
Factor Model
Portfolios
Lazy PortfoliosUser Portfolios
Discussions
VTGN vs. VT
Performance
Risk-Adjusted Performance
Dividends
Drawdowns
Volatility

Correlation

The correlation between VTGN and VT is 0.23, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.


-0.50.00.51.00.2

Performance

VTGN vs. VT - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in VistaGen Therapeutics, Inc. (VTGN) and Vanguard Total World Stock ETF (VT). The values are adjusted to include any dividend payments, if applicable.

-30.00%-20.00%-10.00%0.00%10.00%SeptemberOctoberNovemberDecember2025February
-9.62%
8.41%
VTGN
VT

Key characteristics

Sharpe Ratio

VTGN:

-0.74

VT:

1.75

Sortino Ratio

VTGN:

-1.07

VT:

2.37

Omega Ratio

VTGN:

0.89

VT:

1.32

Calmar Ratio

VTGN:

-0.40

VT:

2.58

Martin Ratio

VTGN:

-1.07

VT:

10.24

Ulcer Index

VTGN:

36.96%

VT:

2.04%

Daily Std Dev

VTGN:

52.01%

VT:

11.97%

Max Drawdown

VTGN:

-99.20%

VT:

-50.27%

Current Drawdown

VTGN:

-98.59%

VT:

0.00%

Returns By Period

In the year-to-date period, VTGN achieves a 0.68% return, which is significantly lower than VT's 5.12% return.


VTGN

YTD

0.68%

1M

0.00%

6M

-9.45%

1Y

-45.20%

5Y*

-31.43%

10Y*

N/A

VT

YTD

5.12%

1M

4.32%

6M

8.41%

1Y

18.59%

5Y*

10.56%

10Y*

9.53%

*Annualized

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.


Risk-Adjusted Performance

VTGN vs. VT — Risk-Adjusted Performance Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

VTGN
The Risk-Adjusted Performance Rank of VTGN is 1414
Overall Rank
The Sharpe Ratio Rank of VTGN is 1010
Sharpe Ratio Rank
The Sortino Ratio Rank of VTGN is 99
Sortino Ratio Rank
The Omega Ratio Rank of VTGN is 1313
Omega Ratio Rank
The Calmar Ratio Rank of VTGN is 2121
Calmar Ratio Rank
The Martin Ratio Rank of VTGN is 1919
Martin Ratio Rank

VT
The Risk-Adjusted Performance Rank of VT is 7171
Overall Rank
The Sharpe Ratio Rank of VT is 7070
Sharpe Ratio Rank
The Sortino Ratio Rank of VT is 6868
Sortino Ratio Rank
The Omega Ratio Rank of VT is 7070
Omega Ratio Rank
The Calmar Ratio Rank of VT is 7373
Calmar Ratio Rank
The Martin Ratio Rank of VT is 7575
Martin Ratio Rank
The risk-adjusted ranks indicate the investment's position relative to the market. A rank closer to 100 signifies top-performing investments, while a rank closer to 0 might suggest underperformance, based on the selected ratio. The values are calculated based on the past 12 months of returns.

VTGN vs. VT - Risk-Adjusted Performance Comparison

This table presents a comparison of risk-adjusted performance metrics for VistaGen Therapeutics, Inc. (VTGN) and Vanguard Total World Stock ETF (VT). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.


Sharpe ratio
The chart of Sharpe ratio for VTGN, currently valued at -0.74, compared to the broader market-2.000.002.004.00-0.741.75
The chart of Sortino ratio for VTGN, currently valued at -1.07, compared to the broader market-6.00-4.00-2.000.002.004.006.00-1.072.37
The chart of Omega ratio for VTGN, currently valued at 0.89, compared to the broader market0.501.001.502.000.891.32
The chart of Calmar ratio for VTGN, currently valued at -0.40, compared to the broader market0.002.004.006.00-0.402.58
The chart of Martin ratio for VTGN, currently valued at -1.07, compared to the broader market-10.000.0010.0020.0030.00-1.0710.24
VTGN
VT

The current VTGN Sharpe Ratio is -0.74, which is lower than the VT Sharpe Ratio of 1.75. The chart below compares the historical Sharpe Ratios of VTGN and VT, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.


Rolling 12-month Sharpe Ratio-1.000.001.002.003.00SeptemberOctoberNovemberDecember2025February
-0.74
1.75
VTGN
VT

Dividends

VTGN vs. VT - Dividend Comparison

VTGN has not paid dividends to shareholders, while VT's dividend yield for the trailing twelve months is around 1.86%.


TTM20242023202220212020201920182017201620152014
VTGN
VistaGen Therapeutics, Inc.
0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%
VT
Vanguard Total World Stock ETF
1.86%1.95%2.08%2.20%1.82%1.66%2.32%2.53%2.11%2.39%2.45%2.44%

Drawdowns

VTGN vs. VT - Drawdown Comparison

The maximum VTGN drawdown since its inception was -99.20%, which is greater than VT's maximum drawdown of -50.27%. Use the drawdown chart below to compare losses from any high point for VTGN and VT. For additional features, visit the drawdowns tool.


-100.00%-80.00%-60.00%-40.00%-20.00%0.00%SeptemberOctoberNovemberDecember2025February
-98.59%
0
VTGN
VT

Volatility

VTGN vs. VT - Volatility Comparison

VistaGen Therapeutics, Inc. (VTGN) has a higher volatility of 10.15% compared to Vanguard Total World Stock ETF (VT) at 3.05%. This indicates that VTGN's price experiences larger fluctuations and is considered to be riskier than VT based on this measure. The chart below showcases a comparison of their rolling one-month volatility.


0.00%5.00%10.00%15.00%20.00%SeptemberOctoberNovemberDecember2025February
10.15%
3.05%
VTGN
VT
PortfoliosLab logo
Performance Analysis
Portfolio AnalysisPortfolio PerformanceStock ComparisonSharpe RatioMartin RatioTreynor RatioSortino RatioOmega RatioCalmar RatioSummers Ratio
Community
Discussions


Disclaimer

The information contained herein does not constitute investment advice and made available for educational purposes only. Prices and returns on equities are listed without consideration of fees, commissions, taxes, penalties, or interest payable due to purchasing, holding, or selling.

Copyright © 2025 PortfoliosLab